Fundamentals of Transplant and Cellular Therapy-Day 2 - Immunosuppression and Side Effects - Enduring Material - Credit offering period June 16, 2026 - December 31, 2026

Samantha Maples, PharmD, BCOP
*Transplant process/Early and late transplant management

Target Audience

Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant. 

Learning Objectives

Describe the mechanism of action of immunosuppressive agents used in stem cell transplant

Explain the dosing, administration, and necessary monitoring of immunosuppressive agents used to prevent and treat GVHD

Recognize specific adverse effects associated with each immunosuppressive agent

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
Course opens: 
06/16/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0

Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Allegheny General Hospital designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.